Top compounds associated with response to RFX5


Feature Type Standardized
Nominal ANOVA
mRNA JNK-9L GDSC1000 pan-cancer AAC 0.21 4e-07
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA YM201636 GDSC1000 pan-cancer AAC 0.17 5e-06
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.18 6e-06
mRNA KX2-391 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA vincristine CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC 0.17 2e-05
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.17 4e-05
mRNA Doxorubicin GDSC1000 pan-cancer AAC 0.17 5e-05
Download CSV